Global Platelet Rich Plasma Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Platelet Rich Plasma Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Pure PRP
  • 1.4.3 Leukocyte-Rich PRP
  • 1.4.4 Leukocyte-Rich Fibrin
• 1.5 Market by Application
  • 1.5.1 Global Platelet Rich Plasma Market Share by Application (2014-2025)
  • 1.5.2 Orthopedics
  • 1.5.3 Cosmetic Surgery & Dermatology
  • 1.5.4 Ophthalmic Surgery
  • 1.5.5 Neurosurgery
  • 1.5.6 General surgery
  • 1.5.7 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Platelet Rich Plasma Market Size
• 2.2 Platelet Rich Plasma Growth Trends by Regions
  • 2.2.1 Platelet Rich Plasma Market Size by Regions (2014-2025)
  • 2.2.2 Platelet Rich Plasma Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Platelet Rich Plasma Market Size by Manufacturers
  • 3.1.1 Global Platelet Rich Plasma Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Platelet Rich Plasma Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Platelet Rich Plasma Market Concentration Ratio (CR5 and HHI)
• 3.2 Platelet Rich Plasma Key Players Head office and Area Served
• 3.3 Key Players Platelet Rich Plasma Product/Solution/Service
• 3.4 Date of Enter into Platelet Rich Plasma Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Platelet Rich Plasma Market Size by Type (2014-2019)
• 4.2 Global Platelet Rich Plasma Market Size by Application (2014-2019)

5 United States

• 5.1 United States Platelet Rich Plasma Market Size (2014-2019)
• 5.2 Platelet Rich Plasma Key Players in United States
• 5.3 United States Platelet Rich Plasma Market Size by Type
• 5.4 United States Platelet Rich Plasma Market Size by Application

6 Europe

• 6.1 Europe Platelet Rich Plasma Market Size (2014-2019)
• 6.2 Platelet Rich Plasma Key Players in Europe
• 6.3 Europe Platelet Rich Plasma Market Size by Type
• 6.4 Europe Platelet Rich Plasma Market Size by Application

7 China

• 7.1 China Platelet Rich Plasma Market Size (2014-2019)
• 7.2 Platelet Rich Plasma Key Players in China
• 7.3 China Platelet Rich Plasma Market Size by Type
• 7.4 China Platelet Rich Plasma Market Size by Application

8 Japan

• 8.1 Japan Platelet Rich Plasma Market Size (2014-2019)
• 8.2 Platelet Rich Plasma Key Players in Japan
• 8.3 Japan Platelet Rich Plasma Market Size by Type
• 8.4 Japan Platelet Rich Plasma Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Platelet Rich Plasma Market Size (2014-2019)
• 9.2 Platelet Rich Plasma Key Players in Southeast Asia
• 9.3 Southeast Asia Platelet Rich Plasma Market Size by Type
• 9.4 Southeast Asia Platelet Rich Plasma Market Size by Application

10 India

• 10.1 India Platelet Rich Plasma Market Size (2014-2019)
• 10.2 Platelet Rich Plasma Key Players in India
• 10.3 India Platelet Rich Plasma Market Size by Type
• 10.4 India Platelet Rich Plasma Market Size by Application

11 Central & South America

• 11.1 Central & South America Platelet Rich Plasma Market Size (2014-2019)
• 11.2 Platelet Rich Plasma Key Players in Central & South America
• 11.3 Central & South America Platelet Rich Plasma Market Size by Type
• 11.4 Central & South America Platelet Rich Plasma Market Size by Application

12 International Players Profiles

• 12.1 AdiStem Ltd.
  • 12.1.1 AdiStem Ltd. Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Platelet Rich Plasma Introduction
  • 12.1.4 AdiStem Ltd. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.1.5 AdiStem Ltd. Recent Development
• 12.2 Arthrex, Inc.
  • 12.2.1 Arthrex, Inc. Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Platelet Rich Plasma Introduction
  • 12.2.4 Arthrex, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.2.5 Arthrex, Inc. Recent Development
• 12.3 Biomet, Inc.
  • 12.3.1 Biomet, Inc. Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Platelet Rich Plasma Introduction
  • 12.3.4 Biomet, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.3.5 Biomet, Inc. Recent Development
• 12.4 Cesca Therapeutics, Inc.
  • 12.4.1 Cesca Therapeutics, Inc. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Platelet Rich Plasma Introduction
  • 12.4.4 Cesca Therapeutics, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.4.5 Cesca Therapeutics, Inc. Recent Development
• 12.5 DePuy Synthes, Inc.
  • 12.5.1 DePuy Synthes, Inc. Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Platelet Rich Plasma Introduction
  • 12.5.4 DePuy Synthes, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.5.5 DePuy Synthes, Inc. Recent Development
• 12.6 EmCyte Corporation
  • 12.6.1 EmCyte Corporation Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Platelet Rich Plasma Introduction
  • 12.6.4 EmCyte Corporation Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.6.5 EmCyte Corporation Recent Development
• 12.7 Exactech, Inc.
  • 12.7.1 Exactech, Inc. Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Platelet Rich Plasma Introduction
  • 12.7.4 Exactech, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.7.5 Exactech, Inc. Recent Development
• 12.8 Harvest Technologies Corp.
  • 12.8.1 Harvest Technologies Corp. Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Platelet Rich Plasma Introduction
  • 12.8.4 Harvest Technologies Corp. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.8.5 Harvest Technologies Corp. Recent Development
• 12.9 Nuo Therapeutics, Inc.
  • 12.9.1 Nuo Therapeutics, Inc. Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Platelet Rich Plasma Introduction
  • 12.9.4 Nuo Therapeutics, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.9.5 Nuo Therapeutics, Inc. Recent Development
• 12.10 Regen Lab SA
  • 12.10.1 Regen Lab SA Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Platelet Rich Plasma Introduction
  • 12.10.4 Regen Lab SA Revenue in Platelet Rich Plasma Business (2014-2019)
  • 12.10.5 Regen Lab SA Recent Development
• 12.11 Stryker Corporation

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer